BIOMAT Database Logo BIOMAT Database Logo

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. 1995

M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Department of Immunohematology, University Hospital Leiden, The Netherlands.

Previously, we have shown that immunization with human papillomavirus (HPV) type 16-derived cytotoxic T lymphocyte (CTL) epitope E7 49-57 (RAHYNIVTF) renders C57BL/6 mice insensitive to tumors formed by HPV16-transformed cells. In this study, we provide evidence that E7 49-57 is expressed as a subdominant CTL epitope on HPV16-transformed C57BL/6 cells. Using acid peptide elution, it is shown that HPV16-transformed cells express another CTL epitope, besides E7 49-57, which appears to be dominant. We demonstrate that a CTL line raised against the subdominant CTL epitope, offered as synthetic peptide E7 49-57, eradicates established HPV16-induced tumors in mice. Our data show that synthetic peptide-induced CTL can be applied successfully in vivo against (virus-induced) tumor, and emphasize that subdominant CTL epitopes are useful targets for immunotherapy. Furthermore, it is illustrated for the first time that HPV16-specific CTL interfere directly with HPV16-induced tumors.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D014412 Tumor Virus Infections Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Fibroma, Shope,Papilloma, Shope,Infections, Tumor Virus,Infection, Tumor Virus,Shope Fibroma,Shope Papilloma,Tumor Virus Infection
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
July 1997, The Journal of general virology,
M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells.
September 1993, European journal of immunology,
M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor.
August 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy,
M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope.
November 1998, Journal of immunotherapy (Hagerstown, Md. : 1997),
M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein.
October 1997, The Journal of general virology,
M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.
October 2000, International journal of cancer,
M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination.
March 1993, Journal of immunology (Baltimore, Md. : 1950),
M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Synthetic peptides induce a cytotoxic response against human papillomavirus type-18.
July 2001, Gynecologic oncology,
M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
[Peptide-induced cytotoxic T lymphocytes].
May 2002, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M C Feltkamp, and G R Vreugdenhil, and M P Vierboom, and E Ras, and S H van der Burg, and J ter Schegget, and C J Melief, and W M Kast
Efficacy of cytotoxic T lymphocytes against virus-induced tumors.
April 1990, Cancer cells (Cold Spring Harbor, N.Y. : 1989),
Copied contents to your clipboard!